Quick answers
What to know before the next decision
What are the main localized-treatment families?
External-beam radiation delivers treatment from outside the body; brachytherapy places a radiation source in or near the prostate. The exact technique, dose, schedule, and use of hormone therapy depend on the individual cancer and patient.
Is SBRT a different kind of cancer treatment?
Stereotactic body radiation therapy, or SBRT, is a highly focused external-beam approach delivered in fewer, larger treatment fractions for selected patients. Fewer visits do not make it automatically safer or better.
How is success monitored?
PSA usually declines differently after radiation than after prostate removal because the prostate remains. The radiation and urology teams should define the PSA schedule, expected pattern, symptoms to report, and escalation criteria.
Treatment map
Compare the radiation plan by clinical job
Names and schedules vary. Use the table to ask why one plan fits the cancer, anatomy, health, and priorities.
| Approach | Questions that distinguish the plan |
|---|---|
| External-beam radiation | What target is treated, how many fractions are planned, what image guidance is used, and whether pelvic nodes or another area are included? |
| SBRT | Why is a shorter high-dose schedule appropriate, what motion and organ-protection methods are used, and how do baseline urinary symptoms affect candidacy? |
| Brachytherapy | Is the plan low-dose-rate seed implantation or high-dose-rate temporary treatment, and how do prostate size, urinary function, anesthesia, and combination therapy affect fit? |
| After prostatectomy | Is radiation being discussed because of pathology, a PSA pattern, or visible recurrence, and what do timing, PSMA PET, treatment field, and hormone therapy change? |
Use the chart carefully. This is a question map, not a treatment recommendation. Technique names, eligibility, dose, fractionation, and combined therapy require individualized radiation-oncology review.
Start with the cancer question
Radiation may be considered as primary treatment for localized or locally advanced disease, after surgery when pathology or PSA raises concern, or to control selected metastatic sites or symptoms. Those settings are not interchangeable.
Ask the clinician to state the stage and risk group, treatment goal, target area, and evidence that makes radiation appropriate now. If cure is the goal, compare reasonable alternatives with the same specificity rather than comparing a detailed radiation plan with a vague description of surgery or surveillance.
External-beam techniques share a family but not one schedule
External-beam radiation uses a machine outside the body. Modern plans may use intensity-modulated and image-guided methods; selected patients may be offered conventional, moderately hypofractionated, or stereotactic schedules.
The number of visits is only one dimension. Ask about target definition, organ motion, bladder and rectal preparation, image guidance, dose per fraction, treatment interruptions, and why the schedule fits the risk and baseline function.
Each schedule is billed one delivery session at a time; the prostate cancer radiation treatment cost guide in the related reading shows the 2026 Medicare rate for 5-session SBRT, 20- to 28-session, and 39- to 45-session courses.
Brachytherapy places treatment inside or near the prostate
Brachytherapy can use permanent low-dose-rate seeds or temporary high-dose-rate sources. It may be offered alone or with external-beam treatment in selected clinical situations.
Prostate size and anatomy, urinary obstruction, prior procedures, anesthesia, seed or catheter precautions, and the treating center's experience can change candidacy. Ask what remains in the body, what radiation-safety instructions apply, and who manages urinary symptoms after the procedure.
For what needle placement, each HDR session, and the sources cost under Medicare's 2026 schedule, the prostate cancer radiation treatment cost guide in the related reading lists the billing figures.
Hormone therapy is a separate decision inside the radiation plan
Androgen-deprivation therapy may be recommended with radiation for some risk groups or clinical settings, but the drug, start date, duration, expected benefit, and side-effect plan should be explicit.
Discuss hot flashes, sexual function, bone and metabolic health, cardiovascular context, mood and cognition concerns, and which clinician owns monitoring. Do not assume every radiation plan includes hormone therapy or that one duration fits every risk category.
Prepare for simulation and daily logistics
External-beam treatment commonly begins with planning imaging and positioning. The center may provide bladder, bowel, marker, spacer, skin, medicine, and nutrition instructions based on the technique; follow that center's protocol rather than a generic checklist.
Confirm the number and length of visits, whether a support person is needed, transportation, work impact, what happens after a missed session, and whom to call for urinary, bowel, pain, skin, fatigue, or other symptoms during treatment.
Separate early effects from late effects
Urinary frequency, urgency or burning, bowel changes, fatigue, and skin or pelvic symptoms may occur during or soon after treatment. Sexual, urinary, bowel, bone, and other effects can also appear or persist later. The pattern and likelihood depend on the field, dose, technique, baseline function, prior treatment, medicines, and health.
Ask which symptoms are expected, which are treatable, which require same-day contact, and what baseline information should be recorded before treatment. New severe pain, inability to urinate, heavy bleeding, fever, weakness, or another urgent change should follow the care team's emergency instructions.
Define PSA and long-term follow-up before treatment begins
After radiation, PSA often falls over time rather than immediately becoming undetectable because prostate tissue remains. A temporary rise can occur, and recurrence is not determined from a screening reference range or one isolated value.
Ask for the PSA schedule, the expected pattern for this treatment, how a possible bounce is distinguished from persistent concern, when imaging such as PSMA PET might enter the pathway, and which urology, radiation-oncology, or medical-oncology team owns long-term follow-up.
Frequently asked questions
Prostate-radiation questions, answered
How many radiation treatments are needed for prostate cancer?
The schedule can range from a small number of stereotactic fractions to several weeks of external-beam treatment, while brachytherapy follows a different procedure pathway. Cancer risk, anatomy, technique, prior treatment, and center protocol determine the plan.
Is radiation better than prostate surgery?
Neither is universally better. For some localized cancers both can be reasonable, but side-effect timing, pathology information, urinary and sexual baseline, age, health, cancer risk, and patient priorities differ. A balanced consultation should compare both for the same clinical case.
What are the most common side effects?
Urinary, bowel, fatigue, and sexual effects are commonly discussed, but the timing and likelihood vary by technique, field, dose, hormone therapy, baseline function, and prior treatment. Ask for outcomes that match the exact plan.
Does radiation make PSA go to zero?
Not necessarily. The prostate remains after most radiation treatment, so PSA usually follows a different pattern than after radical prostatectomy. The treating team should define the expected decline and follow-up criteria.
Can radiation be used after prostate surgery?
Yes, in selected situations when pathology or a postoperative PSA pattern suggests residual or recurrent disease. Timing, PSA trend, imaging, treatment field, and hormone therapy need individualized review.
Bring these questions
Make the next appointment concrete.
- What is the treatment goal, target, and risk group?
- Why does this technique and fraction schedule fit me?
- Is hormone therapy recommended, for how long, and who manages its effects?
- How do my baseline urinary, bowel, sexual, and general health factors change the plan?
- Which symptoms require same-day contact during or after treatment?
- What exact PSA and imaging follow-up will show whether the plan is working?
Sources and further reading
These primary references support the educational guide reviewed by Domenico Savatta, MD on August 12, 2026. They do not replace guidance from your own clinician.